- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Is CRISPR Therapeutics Stock Going to $0, or Will the Hype Pay Off? | ||
| Fr | 3 Monster Stocks to Hold for the Next 20 Years | ||
| Fr | Why EPAM Systems Sank This Week | ||
| Fr | How This AI Stock Went From Lost Cause to Leading Force | ||
| Fr | 1 Brilliant Vanguard Index Fund to Buy Before It Soars 25%, According to Wall Street Analysts | ||
| Fr | Why Copart Stock Dropped Today | ||
| Fr | My Top Artificial Intelligence (AI) Stock to Buy in 2026 | ||
| Fr | Canopy Growth or Tilray Brands: Which Stock Is More Likely to Be a Millionaire Maker? | ||
| Fr | Why Did Bloom Energy Stock Pop Again This Week? | ||
| Fr | These 3 Sectors Are Crushing Tech in 2026. Time to Invest? | ||
| Fr | Meta Platforms vs. Netflix: Which Is the Better Growth Stock to Buy? | ||
| Fr | Why Red Cat Stock Popped Today -- Then Dropped | ||
| Fr | Bitcoin vs. Ethereum: Which Is the Smarter Buy for 2026 and Beyond? | ||
| Fr | Where Will Lucid Stock Be in 10 Years? | ||
| Fr | Got $5,000? Here's the Ultimate Pick-and-Shovel Pet Stock (Spoiler: It's Not Chewy) | ||
| Fr | Time to Buy the Dip on Vistra Stock? | ||
| Fr | How Much Cheaper Are International Stocks Than U.S. Stocks? | ||
| Fr | Why Hycroft Mining Stock Was Up Close to 20% This Week | ||
| Fr | Here's How Morgan Stanley Beats the Market From Here | ||
| Fr | The Gene-Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices | ||
| Fr | Battle Royale: Nebius vs. UiPath. Only One Can Make You Rich. | ||
| Fr | Prediction: 2 Stocks That Should Be Worth More Than Nvidia 10 Years From Now | ||
| Fr | 1 Semiconductor ETF to Buy Hand Over Fist and 1 to Avoid | ||
| Fr | Better Dividend Stock: Energy Transfer vs. Enterprise Products Partners in 2026 | ||
| Fr | 2 Incredibly Popular Stocks to Sell Before They Plummet |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.